AfterNext HealthTech Acquisition Corp
AFTR
AFTR was delisted on the 14th of August, 2023.
0 hedge funds and large institutions have $0 invested in AfterNext HealthTech Acquisition Corp in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 47 closing their positions.
100% less funds holding
Funds holding: 47 → 0 (-47)
100% less capital invested
Capital invested by funds: $233M → $0 (-$233M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 47
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$22.7M |
| 2 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
-$19.7M |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$18.6M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$14.5M |
| 5 |
GCL
Glazer Capital LLC
New York
|
-$13M |
AFTR Hedge Fund Activity: Q3 2023 in Review
0 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in AfterNext HealthTech Acquisition Corp (AFTR) for Q3 2023, worth a combined $0 — down 100% from $233M a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of AFTR and 0 opened new positions — a net loss of 47 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Aristeia Capital, exiting entirely with an estimated $22.7M sold.
- 0 institutional investors held AfterNext HealthTech Acquisition Corp (AFTR) as of Q3 2023, down from 47 in Q2 2023.
- Funds reported $0 of AfterNext HealthTech Acquisition Corp stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new AfterNext HealthTech Acquisition Corp positions in Q3 2023 and 47 closed out, a net change of -47 holders.
- The largest AfterNext HealthTech Acquisition Corp seller in Q3 2023 was Aristeia Capital, an estimated $22.7M sold.
Based on aggregated 13F filings for Q3 2023.